These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21544945)

  • 1. Successful treatment of multiple keratoacanthoma with topical imiquimod and low-dose acitretin.
    Barysch MJ; Kamarashev J; Lockwood LL; Dummer R
    J Dermatol; 2011 Apr; 38(4):390-2. PubMed ID: 21544945
    [No Abstract]   [Full Text] [Related]  

  • 2. Eruptive keratoacanthoma and squamous cell carcinoma complicating imiquimod therapy: response to oral acitretin.
    Foxton G; Delaney T
    Australas J Dermatol; 2011 Feb; 52(1):66-9. PubMed ID: 21332698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dramatic clearance of HIV-associated bowenoid papulosis using combined oral acitretin and topical 5% imiquimod.
    Lim JH; Lim KS; Chong WS
    J Drugs Dermatol; 2014 Aug; 13(8):901-2. PubMed ID: 25116965
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of basal cell carcinomas in a patient with xeroderma pigmentosum with a combination of imiquimod 5% cream and oral acitretin.
    Giannotti B; Vanzi L; Difonzo EM; Pimpinelli N
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():33-5. PubMed ID: 14616811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case series of multiple recurrent reactive keratoacanthomas developing at surgical margins.
    Hadley JC; Tristani-Firouzi P; Florell SF; Bowen GM; Hadley ML
    Dermatol Surg; 2009 Dec; 35(12):2019-24. PubMed ID: 19758354
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients.
    Tiodorovic-Zivkovic D; Zalaudek I; Longo C; De Pace B; Albertini G; Argenziano G
    Eur J Dermatol; 2012; 22(4):579-80. PubMed ID: 22652500
    [No Abstract]   [Full Text] [Related]  

  • 7. Two cases of squamous cell carcinoma treated with topical imiquimod 5%.
    Oster-Schmidt C
    J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):93-5. PubMed ID: 14678542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive undifferentiated squamous cell carcinoma in an immunosuppressed patient after kidney transplantation.
    Haustein UF; Paasch U
    J Dtsch Dermatol Ges; 2005 Jan; 3(1):44-6. PubMed ID: 16353749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imiquimod as a possible treatment for keratoacanthoma.
    Bhatia N
    J Drugs Dermatol; 2004; 3(1):71-4. PubMed ID: 14964750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel therapeutic combination approach for treating multiple vemurafenib-induced keratoacanthomas: systemic acitretin and intralesional fluorouracil.
    LaPresto L; Cranmer L; Morrison L; Erickson CP; Curiel-Lewandrowski C
    JAMA Dermatol; 2013 Mar; 149(3):279-81. PubMed ID: 23552479
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe exacerbation of multiple self-healing squamous epithelioma (Ferguson-Smith disease) with radiotherapy, which was successfully treated with acitretin.
    Robertson SJ; Bashir SJ; Pichert G; Robson A; Whittaker S
    Clin Exp Dermatol; 2010 Jun; 35(4):e100-2. PubMed ID: 19874360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75%: a case report.
    Dirschka T; Schmitz L; Bartha Á
    Eur J Dermatol; 2016 Aug; 26(4):408-9. PubMed ID: 27097553
    [No Abstract]   [Full Text] [Related]  

  • 13. Case of keratoacanthoma centrifugum marginatum treated with acitretin.
    Mehrtens SH; de la Hera I; Shankar S
    BMJ Case Rep; 2018 Nov; 2018():. PubMed ID: 30389737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse lichenplanopilaris and multiple squamous neoplasms.
    Sutton L; Eduardo C; Butler DF
    Dermatol Online J; 2015 Jan; 21(1):. PubMed ID: 25612122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imiquimod - Its role in the treatment of cutaneous malignancies.
    Bubna AK
    Indian J Pharmacol; 2015; 47(4):354-9. PubMed ID: 26288465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Tillman DK; Carroll MT
    Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream.
    Schroeder TL; Sengelmann RD
    J Am Acad Dermatol; 2002 Apr; 46(4):545-8. PubMed ID: 11907505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined imiquimod and acitretin for non-surgical treatment of basal cell carcinoma.
    Ingves C; Jemec GB
    Scand J Plast Reconstr Surg Hand Surg; 2003; 37(5):293-5. PubMed ID: 14649688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual cutaneous-polyposis syndrome stabilized with acitretin.
    Schmulewitz L; Attard N; Fearfield L; Westaby D; Prasad P; Thomas HJ; Bunker CB
    Br J Dermatol; 2008 Jul; 159(1):228-30. PubMed ID: 18503591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of invasive squamous cell carcinoma with 5-percent imiquimod cream.
    Konstantopoulou M; Lord MG; Macfarlane AW
    Dermatol Online J; 2006 Mar; 12(3):10. PubMed ID: 16638424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.